Journal of Mahatma Gandhi University of Medical Sciences and Technology

Register      Login

VOLUME 3 , ISSUE 3 ( September-December, 2018 ) > List of Articles

CASE REPORT

Carbamazepine-induced Pancytopenia: A Rare Entity

Pankaj Mathur, Kishore Moolrajani, Vishal Mishra, Ankit Jain

Keywords : Carbamazepine, Pancytopenia

Citation Information : Mathur P, Moolrajani K, Mishra V, Jain A. Carbamazepine-induced Pancytopenia: A Rare Entity. J Mahatma Gandhi Univ Med Sci Tech 2018; 3 (3):97-98.

DOI: 10.5005/jp-journals-10057-0082

License: CC BY-NC 4.0

Published Online: 21-07-2020

Copyright Statement:  Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Carbamazepine is an anticonvulsant medication used primarily in the treatment of epilepsy, seizure disorder, neuropathic pain, some psychiatric disorders such as schizophrenia, and as a second-line agent in bipolar disorders. Generally, it is safe to use with some nonserious side effects. However, a clinician has to be alert regarding some of its uncommon but serious side effects. Here we discuss a rare case who developed carbamazepine-induced pancytopenia. The offending drug was stopped and pancytopenia recovered within a few days.


PDF Share
  1. Brunton L, Chabner B, Knollmann B. The pharmacological basis of therapeutics. 12th ed., McGraw Hill, Goodman and Gilman's; 2011. p. 594.
  2. Satoskar RS, Rege N, Bhandarkar SD. Pharmacology and pharmacotherapeutics, 24th ed., India: Elsevier; 2015. p. 136.
  3. Aster RH, Curtis BR, McFarland JG, et al. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis and management. J Thromb Haemost 2009;7(6):911–918. DOI: 10.1111/j.1538-7836.2009.03360.x.
  4. Shigeyama Y, Hishida H, Doi T, et al. A case of marked thrombocytopenia during administration of carbamazepine. J Jpn Soc Clin Anesth 2005;25(2):162–165. DOI: 10.2199/jjsca.25.162.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.